Product Images Dalfampridine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Dalfampridine NDC 0591-2533 by Actavis Pharma, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

2 - image 1

2 - image 1

This appears to be a medical formula used for calculating creatinine clearance (CrCl), a measure of kidney function. The formula uses the age and weight of the patient, as well as the serum creatinine level, to determine the estimated glomerular filtration rate (eGFR). The text provides the equations for this calculation, which involve multiplying the patient's age (in years) minus 140 by their weight (in kg), and then multiplying the serum creatinine measurement (in mg/dL) by 72. The resulting products are then divided by 1,000, and multiplied together to give an estimated creatinine clearance value in ml/min.*

Chemical Structure - image 2

Chemical Structure - image 2

figure 1 - image 3

figure 1 - image 3

This appears to be a graph or chart showing the results of a clinical trial comparing the effects of placebo versus 10mg of Dalfampridine Extended-release tablets twice a day on walking speed in patients. The percentage of patients achieving certain levels of improvement in walking speed is displayed on the y-axis, while the x-axis shows different thresholds of improvement. P-values are provided for each threshold, indicating statistical significance of the results.*

figure2 - image 4

figure2 - image 4

This text seems to be a statistical data about patients taking Dalfampridine Extended release Tablets compared to patients taking a placebo. The data shows an increase in walking speed from the baseline for patients taking the tablets. The percentages indicate the average increase in walking speed and the P-values obtained at different thresholds for comparison.*

new - image 5

new - image 5

This is a description of a medication with the brand name Teva. The medication comes in the form of film-coated tablets, and each tablet contains 10mg of Dalfampridine. The tablets are sold in containers with child-resistant closures and should be kept out of reach of children. The package insert provides dosage information, and it is recommended that the tablets are taken whole and not divided, crushed, chewed or dissolved. The medication should be stored at 20°10 to 25°C (68°to 77°F) and is manufactured for Teva Pharmaceuticals USA, Inc. The package contains 60 tablets, and there is a serialization coding area included. It is only available with a prescription and comes with a guide for each patient.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.